| MedaSorb Technologies (MSBT.OB) Draws Closer to Completion of Human Clinical ... - Reuters |
|
|
ReutersConsidering that the company has stated that treatment has been well-tolerated by patients and easily administered by hospital staff on standard dialysis ... read more |